Search Within

Jae Hong Park

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (7)
  3. Correspondence (1)
  4. Research Letter (1)
Groups
  1. Adult Leukemia (19)
  2. Center for Hematologic Malignancies (19)
  3. Department of Medicine (19)
  4. Hematologic Malignancies, Division of (19)
  5. Population Sciences Research Program (19)
  6. Epidemiology and Biostatistics (17)

More Groups

People
  1. Mark Geyer (8)
  2. Martin Tallman (8)
  3. Sergio Giralt (8)
  4. Andriy Derkach (7)
  5. Gunjan Shah (7)
  6. Maria Palomba (7)

More People

Years
  1. 2025 (3)
  2. 2023 (5)
  3. 2022 (2)
  4. 2020 (2)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. Blood (10)
  2. Blood Advances (2)
  3. Leukemia and Lymphoma (2)
  4. Biology of Blood and Marrow Transplantation (1)
  5. Breast Cancer Research and Treatment (1)
  6. Nature Medicine (1)

More Publications

Publishers
  1. American Society of Hematology (12)
  2. Taylor & Francis Group (2)
  3. Elsevier Inc. (1)
  4. Elsevier Science, Inc. (1)
  5. Massachusetts Medical Society (1)
  6. Nature Publishing Group (1)

More Publishers

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of additional cytogenetic abnormalities and complex karyotype on event-free survival in acute promyelocytic leukemia: Analysis from a single academic center plus the APML4 study
    Meeting Abstract

    Epstein-Peterson, Z. D.; Rajeeve, S.; Derkach, A.; Park, J. H.; Stein, E. M.; Zhang, Y.; Iland, H. J.; Tallman, M. S.
    Blood (2020)

    Fulltext@MSK | Save
  • Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naìˆve acute lymphoblastic leukemia
    Correspondence

    Gaulin, C.; Chan, A.; Derkach, A.; Park, J. H.; Mantha, S.; Geyer, M. B.; Tallman, M. S.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies
    Meeting Abstract

    Pichardo, J. D.; Feldstein, J. T.; Arcila, M.; Batlevi, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.; Tallman, M. S.; Stein, E. M.; Klimek, V. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
    Journal Article

    Park, J. H.; Qiao, B.; Panageas, K. S.; Schymura, M. J.; Jurcic, J. G.; Rosenblat, T. L.; Altman, J. K.; Douer, D.; Rowe, J. M.; Tallman, M. S.
    Blood (2011)

    Fulltext@MSK | Save
  • A population-based study in acute promyelocytic leukemia (APL) suggests a higher early death rate and lower overall survival than commonly reported in clinical trials: Data from the Surveillance, Epidemiology, and End Results (SEER) program and the New York State Cancer Registry in the United States between 1992-2007
    Journal Article

    Park, J. H.; Panageas, K. S.; Schymura, M. J.; Qiao, B.; Jurcic, J. G.; Rosenblat, T. L.; Altman, J. K.; Douer, D.; Rowe, J. M.; Tallman, M. S.
    Blood (2010)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab plus dose-dense doxorubicin/cyclophosphamide followed by nanoparticle albumin-bound paclitaxel in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H. L.; Rugo, H.; Paulson, M.; Rourke, M.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Park, J.; more...
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save